Polycyclic amine compounds and their enantiomers, their method o

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514212, 5142355, 5142358, 514252, 514255, 514256, 514318, 514326, 514327, 514330, 514331, 540524, 540597, 540598, 544121, 544122, 544129, 544333, 544357, 544359, 544360, 544365, 544372, 546186, 546187, 546188, 546189, 546190, 546191, 546208, C07D40102, C07D40114, A61K 31445, A61K 3155

Patent

active

053408225

ABSTRACT:
The invention relates to polycyclic amine compounds of formula (I) ##STR1## where Y. m. Ar', n, p, Q, T, q and Z are defined herein. The invention also relates to methods of making the compounds of formula (I) and pharmaceutical compositions which contain the compounds of formula (I). The inventive compounds are useful as neurokinin receptor antagonists, and are useful for the treatment of any substance P-dependent and neurokinin-dependent pathological condition.

REFERENCES:
patent: 3562281 (1971-02-01), Werner et al.
patent: 3718743 (1973-02-01), Shen et al.
patent: 4094987 (1978-06-01), Hasspacher et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Polycyclic amine compounds and their enantiomers, their method o does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polycyclic amine compounds and their enantiomers, their method o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polycyclic amine compounds and their enantiomers, their method o will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-503272

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.